Atlas Trials

Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection

Clinical trial NCT03726099 · UNKNOWN

Trial details

NCT number
NCT03726099
Sponsor
Shandong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2019-03-15
Primary completion
2020-04-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.